Literature DB >> 18606105

Developments in neuroimaging for acute ischemic stroke: diagnostic and clinical trial applications.

Amie W Hsia1, Chelsea S Kidwell.   

Abstract

Over the past several years, active investigation into neuroimaging in the setting of acute ischemic stroke has improved our understanding of and ability to visualize the dynamic pathophysiology of acute cerebrovascular disease. Efforts surrounding the application of multimodal CT and MRI have resulted in a growing body of data from systematic evaluations of different parameters, experience in the use of these techniques in guiding clinical decision making, and clinical trials employing neuroimaging for patient selection, for proof of principle, and as a surrogate outcome measure.

Entities:  

Mesh:

Year:  2008        PMID: 18606105     DOI: 10.1007/s11883-008-0052-9

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


  46 in total

1.  Two tales: hemorrhagic transformation but not parenchymal hemorrhage after thrombolysis is related to severity and duration of ischemia: MRI study of acute stroke patients treated with intravenous tissue plasminogen activator within 6 hours.

Authors:  Götz Thomalla; Jan Sobesky; Martin Köhrmann; Jochen B Fiebach; Jens Fiehler; Olivier Zaro Weber; Anna Kruetzelmann; Thomas Kucinski; Michael Rosenkranz; Joachim Röther; Peter D Schellinger
Journal:  Stroke       Date:  2007-01-04       Impact factor: 7.914

Review 2.  Computed tomography--an increasing source of radiation exposure.

Authors:  David J Brenner; Eric J Hall
Journal:  N Engl J Med       Date:  2007-11-29       Impact factor: 91.245

3.  Accuracy of dynamic perfusion CT with deconvolution in detecting acute hemispheric stroke.

Authors:  Max Wintermark; Nancy J Fischbein; Wade S Smith; Nerissa U Ko; Marcel Quist; William P Dillon
Journal:  AJNR Am J Neuroradiol       Date:  2005-01       Impact factor: 3.825

4.  Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset.

Authors:  Anthony J Furlan; Dirk Eyding; Gregory W Albers; Yasir Al-Rawi; Kennedy R Lees; Howard A Rowley; Christian Sachara; Mariola Soehngen; Steven Warach; Werner Hacke
Journal:  Stroke       Date:  2006-03-30       Impact factor: 7.914

5.  Systematic comparison of perfusion-CT and CT-angiography in acute stroke patients.

Authors:  Jessica C Tan; William P Dillon; Songling Liu; Felix Adler; Wade S Smith; Max Wintermark
Journal:  Ann Neurol       Date:  2007-06       Impact factor: 10.422

6.  The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase.

Authors:  Werner Hacke; Greg Albers; Yasir Al-Rawi; Julien Bogousslavsky; Antonio Davalos; Michael Eliasziw; Michael Fischer; Anthony Furlan; Markku Kaste; Kennedy R Lees; Mariola Soehngen; Steven Warach
Journal:  Stroke       Date:  2004-11-29       Impact factor: 7.914

7.  Development and performance evaluation of the second model 256-detector row CT.

Authors:  Masahiro Endo; Shinichiro Mori; Susumu Kandatsu; Shuji Tanada; Chisato Kondo
Journal:  Radiol Phys Technol       Date:  2007-11-01

8.  Early blood-brain barrier disruption in human focal brain ischemia.

Authors:  Lawrence L Latour; Dong-Wha Kang; Mustapha A Ezzeddine; Julio A Chalela; Steven Warach
Journal:  Ann Neurol       Date:  2004-10       Impact factor: 10.422

9.  Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds.

Authors:  F Fazekas; R Kleinert; G Roob; G Kleinert; P Kapeller; R Schmidt; H P Hartung
Journal:  AJNR Am J Neuroradiol       Date:  1999-04       Impact factor: 3.825

10.  Risk factors of symptomatic intracerebral hemorrhage after tPA therapy for acute stroke.

Authors:  Maarten G Lansberg; Vincent N Thijs; Roland Bammer; Stephanie Kemp; Christine A C Wijman; Michael P Marks; Gregory W Albers
Journal:  Stroke       Date:  2007-06-14       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.